{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:16:25Z","timestamp":1733289385653,"version":"3.30.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Augsburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Eine 70-j\u00e4hrige Patientin wird wegen akuter einseitiger Erblindung des rechten Auges vorgestellt. Bei unauff\u00e4lligem C\u2011reaktivem Protein (CRP) und Blutsenkungsgeschwindigkeit (BSG) wird ein nichtarteriitischer embolischer Verschluss angenommen. Die weitere Anamnese ergibt jedoch den Verdacht auf eine Gro\u00dfgef\u00e4\u00dfvaskulitis, welcher durch die folgende bildgebende Diagnostik best\u00e4tigt wird. Dieser seltene Fall einer Gro\u00dfgef\u00e4\u00dfvaskulitis bei normwertigen Entz\u00fcndungsparametern betont die Bedeutung von Anamnese und gezielter Diagnostik.<\/jats:p>","DOI":"10.1007\/s00393-024-01531-w","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:02:16Z","timestamp":1718373736000},"page":"852-855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unklare Ursache einseitiger Erblindung bei normwertigen Entz\u00fcndungsparametern","Unclear cause of unilateral blindness with normal inflammation parameters"],"prefix":"10.1007","volume":"83","author":[{"given":"Felix","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Helmut","family":"Pfob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Wahle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"1531_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00393-021-01021-3","volume":"80","author":"T Bley","year":"2021","unstructured":"Bley\u00a0T, Guggenberger\u00a0KV (2021) Kombinierte MRT\/MRA f\u00fcr die Diagnostik der RZA. Z\u00a0Rheumatol 80:559\u2013562","journal-title":"Z Rheumatol"},{"key":"1531_CR2","series-title":"practice","first-page":"2023","volume-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical","author":"D Christian","year":"2023","unstructured":"Christian\u00a0D, Sofia\u00a0R, Milena\u00a0B et\u00a0al (2023) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical. practice, Bd. 2023. update. Annals of the Rheumatic Diseases:ard, S\u00a02023\u2013224543"},{"key":"1531_CR3","doi-asserted-by":"crossref","unstructured":"Conticini E, Hellmich B, Frediani B et\u00a0al (2022) Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis. Scand J Rheumatol: 1\u20137","DOI":"10.1080\/03009742.2022.2047311"},{"key":"1531_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B Hellmich","year":"2020","unstructured":"Hellmich\u00a0B, Agueda\u00a0A, Monti\u00a0S et\u00a0al (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79:19\u201330","journal-title":"Ann Rheum Dis"},{"key":"1531_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10067-012-2031-3","volume":"31","author":"A Laria","year":"2012","unstructured":"Laria\u00a0A, Zoli\u00a0A, Bocci\u00a0M et\u00a0al (2012) Systematic review of the literature and a\u00a0case report informing biopsy-proven giant cell arteritis (GCA) with normal C\u2011reactive protein. Clin Rheumatol 31:1389\u20131393","journal-title":"Clin Rheumatol"},{"key":"1531_CR6","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1007\/s10067-020-05116-1","volume":"39","author":"P Martins","year":"2020","unstructured":"Martins\u00a0P, Teixeira\u00a0V, Teixeira\u00a0FJ et\u00a0al (2020) Giant cell arteritis with normal inflammatory markers: case report and review of the literature. Clin Rheumatol 39:3115\u20133125","journal-title":"Clin Rheumatol"},{"key":"1531_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/03009742.2016.1190984","volume":"46","author":"N Naderi","year":"2017","unstructured":"Naderi\u00a0N, Mohammad\u00a0AJ, Turesson\u00a0C (2017) Large vessel involvement in biopsy-proven giant cell arteritis: incidence, distribution, and predictors. Scand J Rheumatol 46:215\u2013221","journal-title":"Scand J Rheumatol"},{"key":"1531_CR8","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.ophtha.2006.05.020","volume":"113","author":"M Parikh","year":"2006","unstructured":"Parikh\u00a0M, Miller\u00a0NR, Lee\u00a0AG et\u00a0al (2006) Prevalence of a\u00a0normal C\u2011reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113:1842\u20131845","journal-title":"Ophthalmology"},{"key":"1531_CR9","doi-asserted-by":"crossref","unstructured":"Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a\u00a0population-based study. Arthritis Care & Research: Official Journal of the American College of Rheumatology 45:140\u2013145","DOI":"10.1002\/1529-0131(200104)45:2<140::AID-ANR166>3.3.CO;2-U"},{"key":"1531_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11926-021-00980-5","volume":"23","author":"E Tombetti","year":"2021","unstructured":"Tombetti\u00a0E, Hysa\u00a0E, Mason\u00a0JC et\u00a0al (2021) Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides. Curr Rheumatol Rep 23:17","journal-title":"Curr Rheumatol Rep"},{"key":"1531_CR11","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1007\/s00259-021-05362-8","volume":"48","author":"KSM Van Der Geest","year":"2021","unstructured":"Van Der Geest\u00a0KSM, Treglia\u00a0G, Glaudemans\u00a0A et\u00a0al (2021) Diagnostic value of [18F]FDG-PET\/CT for treatment monitoring in large vessel vasculitis: a\u00a0systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 48:3886\u20133902","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01531-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T07:03:06Z","timestamp":1733209386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01531-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01531-w","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"7 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0M\u00fcller, C.H.\u00a0Pfob und M.\u00a0Wahle geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}